Assignee
VENTUS THERAPEUTICS U S INC
US·13 granted patents·14 pending applications·69 citations·filing 2021–2025
Top patents by PatentIndex Score
27 records- 0197US11618751B1Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivativesVENTUS THERAPEUTICS U S INC·Filed 2022·Granted Apr 4, 2023·17 cites·5 claims
- 0295US12195460B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2024·Granted Jan 14, 2025·3 cites·6 claims
- 0394US12281112B2Compounds for inhibiting NLRP3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Granted Apr 22, 2025·1 cites·18 claims
- 0492US12168657B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivativesVENTUS THERAPEUTICS U S INC·Filed 2022·Granted Dec 17, 2024·3 cites·9 claims
- 0592US11319319B1Compounds for inhibiting NLRP3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2021·Granted May 3, 2022·45 cites·20 claims
- 0690US12312350B2Compounds for inhibiting NLRP3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Granted May 27, 2025·0 cites·9 claims
- 0788US12441728B2Pyridazine compounds for inhibiting NLRP3VENTUS THERAPEUTICS U S INC·Filed 2023·Granted Oct 14, 2025·0 cites·7 claims
- 0888US12398136B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2024·Granted Aug 26, 2025·0 cites·18 claims
- 0988US2026042757A1Pyridazine compounds for inhibiting nlrp3VENTUS THERAPEUTICS U S INC·Filed 2025·Application pending·0 cites
- 1087US12312351B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2024·Granted May 27, 2025·0 cites·20 claims
- 1187US2025250270A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 1286US12410167B2Pyridazine compounds for inhibiting NLRP3VENTUS THERAPEUTICS U S INC·Filed 2023·Granted Sep 9, 2025·0 cites·17 claims
- 1385US2024158396A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 1483US12331048B2Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitorsVENTUS THERAPEUTICS U S INC·Filed 2023·Granted Jun 17, 2025·0 cites·18 claims
- 1583US2024409540A1PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORSVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 1681US12351578B2Compounds for inhibiting NLRP3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Granted Jul 8, 2025·0 cites·20 claims
- 1780US2025236620A1PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORSVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 1877US2022340567A1Compounds for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Application pending·0 cites
- 1965US2024368131A1Oxoindolinyl amide derivatives for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Application pending·0 cites
- 2064US2024270740A1Inhibitors of cyclic gmp-amp synthase and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 2161US2026008768A1Urea derivatives for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2025·Application pending·0 cites
- 2261US2026007684A1Amide derivatives for inhibiting nlrp3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2025·Application pending·0 cites
- 2360US2025179079A1Hexahydropyrido[4,3-b]indolyl ketone derivatives useful as cgas modulatorsVENTUS THERAPEUTICS U S INC·Filed 2023·Application pending·0 cites
- 2458US2025002487A1Heterocyclic compounds and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2022·Application pending·0 cites
- 2556US12516060B2Solid freebase forms of 5-chloro-2-(4-((2-hydroxy-2-methylpropyl)amino)pyrido[3,4-d]pyridazin-1-yl)phenol for inhibiting NLRP3 and uses thereofVENTUS THERAPEUTICS U S INC·Filed 2024·Granted Jan 6, 2026·0 cites·26 claims
- 2654US2024018138A1PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALSVENTUS THERAPEUTICS U S INC·Filed 2021·Application pending·0 cites
- 2754US2025257077A1BRIDGED BICYCLIC HETEROCYCLOALKYL PYRIDO-[3,4-d]PYRIDAZINE AMINE DERIVATIVES USEFUL AS NLRP3 INHIBITORSVENTUS THERAPEUTICS U S INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VENTUS THERAPEUTICS U S INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →